Attachment of tumor-selective antigens to microparticle carriers stimulates tumor immunity via effects on dendritic cells and interferon pathways.
Molecular Imaging, Inc. is a specialty CRO combining expertise in small animal in-vivo pharmacology and imaging. Our unique pharmaco-IMAGING platform allows for enhanced decision making in your discovery and development programs.
For over 10 years, Molecular Imaging has provided pharmacology services and pioneered the application of multi-modality imaging. We have executed over 3,000 studies, 600 of which involved imaging, to more than 150 pharmaceutical and biotechnology clients.
In the News
Have a look at the latest edition of Envision, Molecular Imaging, Inc.'s quarterly newsletter. Click Here
Preclinical Contract Research Organisation specializing in Multi-Modality Imaging studies across a wide range of Therapeutic Areas that enhance the effectiveness and efficiency of R&D decision making efforts for new drugs, biologics, devices and diagnostics.